Carca 3.125 mg Tablet - Strip of 15

Carca 3.125 mg Tablet is a pharmaceutical formulation that contains Carvedilol, a non-selective beta-adrenergic blocker with additional alpha-blocking properties. This unique combination allows Carca 3.125 mg Tablet to effectively lower blood pressure, slow heart rate, and reduce the workload on the heart. The primary purpose of Carca 3.125 mg Tablet is to manage hypertension and chronic heart failure, making it a vital component in cardiovascular therapy. By blocking beta receptors, Carca 3.125 mg Tablet limits the effects of adrenaline and other stress hormones that typically increase heart rate and contractility. Additionally, the alpha-blocking action of Carca 3.125 mg Tablet relaxes blood vessels, facilitating easier blood flow and reducing vascular resistance. This dual mechanism of action not only helps control blood pressure but also lowers the risk of complications such as stroke, kidney damage, and cardiovascular diseases. In patients suffering from chronic heart failure, Carca 3.125 mg Tablet improves cardiac function over time, reduces hospital admissions, and enhances survival rates. Following a heart attack, Carca 3.125 mg Tablet protects the heart muscle and decreases the likelihood of further cardiac events, supporting long-term recovery. The administration of Carca 3.125 mg Tablet is typically oral, available in tablet form, with dosing often increased gradually under medical supervision to minimize side effects such as dizziness and fatigue. Treatment with Carca 3.125 mg Tablet should always be guided by a healthcare professional, as it is not intended for immediate relief of chest pain or acute heart failure episodes. Abrupt discontinuation of Carca 3.125 mg Tablet is discouraged, as it may exacerbate cardiac symptoms or increase the risk of adverse events. Overall, Carca 3.125 mg Tablet serves as a comprehensive solution for managing various cardiovascular conditions, providing patients with a reliable option for maintaining their health.